Georg Hess (G Hess)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 9

Top Venues

Leukemia

British journal of haematology

Leukemia & lymphoma

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Loretta J Nastoupil, Georg Hess, Miguel Arturo Pavlovsky, Iwona Danielewicz, Jane A Freeman, Alejandro Martin Martin Garcia-Sancho, Valeria Glazunova, Andrew A Grigg, Jing-Zhou Hou, Ann Janssens, Seok-Jin Kim, Zvenyslava Masliak, Pamela McKay, Francesco Merli, Wataru Munakata, Hirokazu Nagai, Muhit Özcan, Meir Preis, Tingyu Wang, Melissa Rowe, Monelle Tamegnon, Rui Qin, Todd Henninger, Madeliene Curtis, Donne Bennett Caces, Catherine Thieblemont, Gilles Andre Salles
Phase 3 SELENE Study: Ibrutinib Plus BR/R-CHOP in Previously Treated Patients with Follicular or Marginal Zone Lymphoma. Blood advances (2023)
Andrés José Maria Ferreri, Kate Cwynarski, Elisa Pulczynski, Christopher P Fox, Elisabeth Schorb, Claudia Celico, Monica Falautano, Alessandro Nonis, Paul La Rosée, Mascia Binder, Alberto Fabbri, Fiorella Ilariucci, Mauro Krampera, Alexander Roth, Claire Hemmaway, Peter W Johnson, Kim M Linton, Tobias Pukrop, Jettes Sønderskov Gørløv, Monica Balzarotti, Georg Hess, Ulrich Bernd Keller, Stephan Stilgenbauer, Jens Peter Panse, Alessandra Tucci, Lorella Orsucci, Francesco Pisani, Manuela Zanni, Stefan W Krause, Hans J Schmoll, Bernd Hertenstein, Mathias Rummel, Jeffery Smith, Lorenz Thurner, Giuseppina Cabras, Elsa Pennese, Maurilio Ponzoni, Martina Deckert, Letterio S Politi, Juergen Finke, Antonella Ferranti, Kelly Cozens, Elvira Burger, Nicoletta Ielmini, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus, null null
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial. Leukemia 36 (7) (2022)
Georg Hess, Andreas Huettmann, Mathias Witzens-Harig, Martin H Dreyling, Ulrich Keller, Reinhard Marks, Thomas Ernst, Christiane Pott, Andreas Viardot, Fabian Frontzek, Marcel Trautmann, Christian Ruckes, Oliver Deuster, Andreas Rosenwald, Matthias Theobald, Georg Lenz
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial. British journal of haematology 198 (3) (2022)
Georg Hess, Martin Dreyling, Lucie Oberic, Eva Gine, Pier Luigi Luigi Zinzani, Kim Linton, Adam Vilmar, Mats Jerkeman, Jenny M H Chen, Anke Ohler, Stephan Stilgenbauer, Catherine Thieblemont, Jonathan Lambert, Vittorio Ruggero Zilioli, Juan-Manuel Sancho, Ana Jiménez-Ubie, Luca Fischer, Toby Andrew Eyre, Sam Keeping, Julie E Park, James J Wu, Rubina Siddiqi, John Reitan, Sally Wade, Gilles Salles
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study. British journal of haematology (2022)
Svenja Petersohn, Gilles Andre Salles, Michael L Wang, James J Wu, Sally W Wade, Claire L Simons, Craig Bennison, Rubina Siddiqi, Weimin Peng, Ioana Kloos, Gab Castaigne, Georg Hess
Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England. Journal of medical economics 25 (1) (2022)
Friederike Bachmann, Martin Schreder, Monika Engelhardt, Christian Langer, Denise Wolleschak, Lars Olof Mügge, Heinz Dürk, Kerstin Schäfer-Eckart, Igor Wolfgang Blau, Martin Gramatzki, Peter Liebisch, Matthias Grube, Ivana Metzler, Florian Bassermann, Bernd Metzner, Christoph Röllig, Bernd Hertenstein, Cyrus Khandanpour, Tobias Dechow, Holger Hebart, Wolfram Jung, Sebastian Theurich, Georg Maschmeyer, Hans Salwender, Georg Hess, Markus Krebs, Leo Rasche, Annamaria Brioli, Kai-Uwe Eckardt, Christian Straka, Swantje Held, Hermann Einsele, Stefan Knop
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM. Cancers 13 (6) (2021)
Felix Freudenberger, Anke Ohler, Matthias Theobald, Georg Hess
Cure rate in the elderly patients with diffuse large B cell lymphoma deteriorates after the age of 80-results from a single-center survey. Annals of hematology 100 (4) (2021)
Martin Dreyling, Igor Aurer, Sergio Cortelazzo, Olivier Hermine, Georg Hess, Mats Jerkeman, Steven Le Gouill, Vincent Ribrag, Marek Trněný, Carlo Visco, Jan Walewski, Francesco Zaja, Pier Luigi Luigi Zinzani
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations. Leukemia & lymphoma 59 (8) (2017)
Georg Hess, U Keller, C W Scholz, M Witzens-Harig, J Atta, C Buske, S Kirschey, C Ruckes, C Medler, C van Oordt, W Klapper, M Theobald, M Dreyling
Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma. Leukemia 29 (8) (2015)

Georg Hess.css-eqlu8i{font-size:small;padding-left:4px;} (G Hess)

Publication Activity (10 Years)

Top Topics

Top Venues

Georg Hess (G Hess)